Key Takeaways
-
Vyleesi (bremelanotide) is the only peptide option for women's low desire with FDA approval, but it is indicated only for premenopausal women with acquired, generalized HSDD causing real distress.
-
In placebo-controlled trials, about 25% of Vyleesi users reported meaningful desire improvement versus about 17% on placebo, so the average benefit is modest and not guaranteed.
-
Vyleesi is used as an as-needed injection at least 45 minutes before sex, with no more than one dose in 24 hours and eight doses per month.
-
Nausea (about 40% in trials) is the most common side effect and top reason for stopping; Vyleesi can temporarily raise blood pressure and cause skin darkening, and is not for women with uncontrolled high blood pressure or cardiovascular disease.
-
Oxytocin and kisspeptin lack FDA approval for women's libido, and evidence is limited or investigational, so marketing claims should not be treated as proven results.
-
Compounded or online PT-141 is not FDA-reviewed for safety, effectiveness, or quality, so identity, strength, and sterility are uncertain; work with a licensed provider and do a full health evaluation first.
If your desire has been quietly fading, you are far from alone. Many women notice changes in libido during their 30s, 40s, and beyond, and they start searching for answers. Soon they find a confusing world of peptides, injections, and bold online claims. So what is actually proven, and what is just hype?
Here is the honest truth about women’s sexual health peptide therapy. One option has real FDA approval and clinical trial data. Others are still being studied, and the marketing often runs far ahead of the science. That gap matters a lot for your safety and your wallet.
In this guide, we compare the FDA-approved option, bremelanotide (Vyleesi), with the wellness peptides you may see online, like oxytocin and kisspeptin. We will cover how each works, what the research says, and who may be a good fit. We will also talk about why a full health check comes first. Think of this as a friendly chat with a well-informed friend, so you can walk into a provider visit feeling confident.
What Is Peptide Therapy for Women’s Sexual Health?
Peptides are short chains of amino acids. They act as signals in your body, telling cells what to do. Some peptides affect hormones, some affect the brain, and some affect tissue repair. If you want a simple primer, this explainer on what are peptides is a good place to start.
In women’s sexual health, peptide therapy usually means using a peptide to support sexual desire. The most studied example works through the brain’s melanocortin pathways, which are linked to arousal and desire. This is different from a hormone like estrogen or testosterone, which works through the body’s hormone system.
It also helps to know what peptide therapy is not. It is not a magic switch. It does not treat every cause of low desire. And it is not one single product. The phrase covers very different options, with very different levels of proof.
If you are new to the topic, our guide on whether there is peptide therapy for women’s sexual wellness gives helpful background.
The FDA-Approved Option: Bremelanotide (Vyleesi)
Let’s start with the one option that has a clear regulatory stamp. Bremelanotide, also called PT-141 and sold as Vyleesi, received U.S. FDA approval in 2019. It is a prescription melanocortin-receptor agonist.
Who It Is Approved For
Vyleesi is approved for a narrow group. It is meant for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). That means:
- Low desire that was not always present (acquired)
- Low desire in all situations, not just with one partner (generalized)
- Low desire that causes real personal distress
- Low desire that is not mainly explained by a medical or psychiatric condition, relationship problems, or a medication or drug
That last point is important. A clinician needs to rule out other causes before this treatment makes sense.
How It Is Used
Vyleesi is an as-needed injection, not a daily treatment. According to the FDA label, the steps look like this:
- Inject 1.75 mg under the skin of the abdomen or thigh.
- Use it at least 45 minutes before expected sexual activity.
- Take no more than one dose in 24 hours.
- Take no more than eight doses per month.
Many women like that it is used only when needed. Others find the planning part less spontaneous. Both views are valid.
How Well Does Vyleesi Work?
Here is where honesty really matters. In the two main placebo-controlled trials, Vyleesi did help more than placebo, but the average benefit was modest.
| Outcome in Clinical Trials | Vyleesi | Placebo |
|---|---|---|
| Meaningful improvement in desire | About 25% | About 17% |
| Reduced distress about low desire | About 35% | About 31% |
In plain terms, some women saw a real change, and many did not. These numbers describe groups in a study. They are not a promise for any one person.
So Vyleesi is not a general libido booster. It will not fix low desire caused by pain, stress, mood changes, or relationship strain. It is a targeted tool for a specific diagnosis.
Side Effects and Safety to Know About
Every treatment has trade-offs, and this one is no different. Knowing them up front helps you decide with clear eyes.
Common Side Effects
- Nausea: reported by about 40% of participants in trials, and the top reason people stopped treatment
- Flushing
- Headache
- Injection-site reactions
About 13% of participants stopped treatment because of side effects, with nausea leading the way.
Important Warnings From the Label
| Concern | What the FDA Label Says |
|---|---|
| Blood pressure and heart rate | Can temporarily raise blood pressure (often peaking 2 to 4 hours after a dose) and lower heart rate; usually resolves within 12 hours |
| Heart and BP conditions | Not for women with uncontrolled high blood pressure or known cardiovascular disease |
| Skin darkening | Can cause focal hyperpigmentation, including face, gums, or breasts; may not fully fade after stopping |
| Digestion and other medicines | May slow stomach emptying and affect absorption of some oral medicines, including naltrexone |
These are real considerations. A licensed provider should review your health history, blood pressure, and current medicines before prescribing anything.
Wellness Peptides: Oxytocin, Kisspeptin, and Online PT-141
Now for the other side of the comparison. You may see oxytocin, kisspeptin, or compounded PT-141 promoted for libido and intimacy. These do not share the same FDA-approved indication or the same depth of evidence as Vyleesi.
- Oxytocin: often called the bonding hormone, but a 2026 broad review of peptide therapies in urology and sexual medicine described its efficacy data as limited.
- Kisspeptin: described in that same review as promising but still investigational.
- Compounded or online PT-141: not the same as FDA-approved Vyleesi, and quality can vary.
To be fair, that review looked at 76 studies across sexual medicine in general. It is not direct proof that these peptides treat sexual concerns in women. So any claim that says otherwise deserves a raised eyebrow.
For a deeper look at this very comparison, see approved peptides vs. wellness peptides.
Head-to-Head: Approved vs. Wellness Peptides
| Feature | Vyleesi (Bremelanotide) | Oxytocin, Kisspeptin, Online Products |
|---|---|---|
| FDA approval for women’s low desire | Yes, for acquired, generalized HSDD in premenopausal women | No |
| Strength of evidence | Placebo-controlled trials with modest benefit | Limited or investigational |
| Safety information | Detailed FDA label with warnings | Less clear |
| Product quality review | FDA-reviewed manufacturing | Compounded or internet products are not reviewed by FDA for safety, effectiveness, or quality |
| Best for | Women who meet the specific diagnosis | No established use; discuss with a clinician |
The takeaway is simple. If a peptide is going to be part of your plan, the approved option has the clearest track record. Wellness peptides may be interesting, but they should be viewed as unproven.
The Quality Problem With Online Peptides
This part is worth slowing down for. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are sold. Products bought from random websites can have uncertain identity, strength, and sterility. In plain words, you may not know what is really in the vial.
The online “sex peptide” market has been growing, and so have the health risks that come with it. Injecting something unverified is a risk no one should take lightly.
A safer path is to work with licensed providers who prescribe appropriately and use trusted pharmacies. Our article on how to know online peptide therapy is safe walks through the red flags and green flags.
Why a Full Evaluation Comes First
Low desire is rarely about one thing. Before any peptide enters the picture, a good clinician looks at the whole story. Common contributors include:
- Pain during sex
- Menopause-related changes
- Medications, such as some antidepressants
- Mood, anxiety, or depression
- Health conditions and fatigue
- Stress and busy schedules
- Relationship factors
A diagnosis of HSDD requires clinical evaluation and real distress. Treatment should then be matched to you. Sometimes the answer is hormone support. Sometimes it is sleep, stress care, or a medication change. Sometimes it is a peptide.
Lab work often helps here, too. Learn more about lab work for peptide therapy and what to test. If hormones are part of the puzzle, you may also like our guide on real treatments for low libido in women.
Who Might Be a Good Fit for Peptide Care?
Different readers come to this topic from different places. Here is how it may apply to you:
- Health optimizers and wellness seekers: You like evidence and a plan. Focus on the approved option and a full workup rather than trendy products.
- Aging adults and midlife women: Menopause changes can affect desire in many ways. Ask about all options, not only peptides.
- Biohackers: Labs and tracking are your friends, but be extra careful with unverified products, since the evidence is thin.
- Busy professionals: Telehealth can make appointments and at-home delivery much easier to manage.
Also remember that Vyleesi is labeled for premenopausal women. If you are postmenopausal, talk with a provider about what fits your situation. Our article on peptides for women’s desire goes deeper on this.
A Simple Path to Safer Care
If you are curious about peptide therapy for sexual wellness, here is a calm, step-by-step way to move forward:
- Write down your symptoms, when they started, and how much they bother you.
- List your medications, supplements, and health conditions.
- Book a visit with a licensed provider who can review your history.
- Complete recommended blood work to look at hormones and overall health.
- Discuss approved options first, and ask clearly about risks.
- Follow up regularly so your plan can be adjusted.
You deserve care that listens. At Allura Longevity, licensed providers build personalized plans from your blood work and goals, with at-home delivery and ongoing monitoring through telehealth. It is a convenient way to get expert guidance without rearranging your whole week.
The Bottom Line
When it comes to women’s sexual health peptide therapy, the comparison is clear. Vyleesi has FDA approval, trial data, and a detailed safety label, though its average benefit is modest and it fits a narrow group of women. Other peptides, like oxytocin and kisspeptin, remain limited or investigational, and online products carry added quality worries.
The best first step is not a vial. It is a thoughtful conversation and a full health check. When you know the real cause of your changes, you can choose a plan that truly fits.
Ready to talk it through with someone who knows this space? Request a consultation with Allura Longevity and take the first step toward a plan built just for you. New client spots are limited each month, and you can reach the team at (813) 510-6277. Allura Longevity is licensed in Florida, Georgia, Texas, Connecticut, Indiana, Maryland, New York, and California.
This article is for education only and is not medical advice. Always talk with a qualified clinician about your own health. Research summaries are also available through the National Library of Medicine.
FAQs
Q: Is PT-141 (bremelanotide) FDA-approved for women?
A: Yes, but only in a specific way. Bremelanotide, sold as Vyleesi, was approved in 2019 for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women when low desire causes real distress. Compounded or online PT-141 products are not the same as the FDA-approved version.
Q: How effective is Vyleesi for low sexual desire?
A: In the main clinical trials, about 25% of women on Vyleesi reported meaningful improvement in desire, compared with about 17% on placebo. That is a modest average benefit, and results vary from person to person, so it is best discussed with a licensed provider.
Q: What are the side effects and risks of PT-141 for women?
A: Common side effects include nausea, flushing, headache, and injection-site reactions. The FDA label also warns about temporary blood pressure increases, skin darkening, and effects on how some oral medicines are absorbed. It is not for women with uncontrolled high blood pressure or known cardiovascular disease.
Q: Are oxytocin or kisspeptin proven treatments for women’s libido?
A: Not at this time. A 2026 review described kisspeptin as promising but investigational and oxytocin as having limited efficacy data. Marketing claims for these peptides should not be treated as proven results.
Q: Is compounded or online PT-141 safe?
A: It carries more uncertainty than the FDA-approved product. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are sold, and internet-sourced products may have unclear identity, strength, and sterility. Working with a licensed provider is a much safer route.
